Search

Your search keyword '"Castle, Jessica R."' showing total 288 results

Search Constraints

Start Over You searched for: Author "Castle, Jessica R." Remove constraint Author: "Castle, Jessica R."
288 results on '"Castle, Jessica R."'

Search Results

1. Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort

2. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

7. Effect of Impaired Awareness of Hypoglycemia on Glucose Decline During and After Exercise in the T1DEXI Study.

10. Artificial Intelligence and Machine Learning for Improving Glycemic Control in Diabetes: Best Practices, Pitfalls, and Opportunities

11. Fabrication and Characterization of an Amperometric Glucose Sensor on a Flexible Polyimide Substrate

14. Combining uncertainty-aware predictive modeling and a bedtime Smart Snack intervention to prevent nocturnal hypoglycemia in people with type 1 diabetes on multiple daily injections

15. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

16. Combining uncertainty-aware predictive modeling and a bedtime Smart Snack intervention to prevent nocturnal hypoglycemia in people with type 1 diabetes on multiple daily injections.

17. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

18. Accuracy of Wrist-Worn Activity Monitors During Common Daily Physical Activities and Types of Structured Exercise: Evaluation Study

20. The Type 1 Diabetes and EXercise Initiative (T1DEXI): Examining the acute glycemic effects of different types of structured exercise sessions in type 1 diabetes in a real-world setting

21. “The Times They Are A-Changin’” at Diabetes Care

22. Assessment of a Decision Support System for Adults with Type 1 Diabetes on Multiple Daily Insulin Injections

23. Supplemental Materials for 'Quantifying Insulin-Mediated and Non-Insulin-Mediated Changes in Glucose Dynamics during Resistance Exercise in Type 1 Diabetes'

24. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

25. 241-OR: Increased Time in Range on Days with Structured Aerobic, Interval, or Resistance Exercise as Compared with Sedentary Days, in Adults with Type 1 Diabetes (T1D)

26. 771-P: Acceptance of Decision Support Recommendations Improves Time in Range for People Living with Type 1 Diabetes on Multiple Daily Injections

27. 292-OR: Changes in Glycemia during Exercise Differ for Aerobic, Interval, and Resistance Workouts with No Impact of Insulin Delivery Modality for Adults with Type 1 Diabetes (T1D)

28. 240-OR: Quantifying Glucose Utilization and Endogenous Glucose Production during Resistance Exercise in People with Type 1 Diabetes (T1D)

29. 291-OR: Using the Performance in Exercise and Knowledge (PEAK) Guidelines Incorporated in a Smartphone-Based Decision Support System Improves Glucose Outcomes during Free-Living Exercise

30. Examining the Acute Glycemic Effects of Different Types of Structured Exercise Sessions in Type 1 Diabetes in a Real-World Setting: The Type 1 Diabetes and Exercise Initiative (T1DEXI).

31. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

33. sj-pdf-1-dst-10.1177_19322968221085273 – Supplemental material for A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

37. 32-LB: Interstitial Glucose Levels during Exercise in Persons with and without Type 1 Diabetes

40. More Time in Glucose Range During Exercise Days than Sedentary Days in Adults Living with Type 1 Diabetes

41. Separating insulin-mediated and non-insulin-mediated glucose uptake during and after aerobic exercise in type 1 diabetes

42. Assessing Mealtime Macronutrient Content: Patient Perceptions Versus Expert Analyses via a Novel Phone App

47. Measuring glucose at the site of insulin delivery with a redox-mediated sensor

49. Dual-hormone closed loop system using a liquid stable glucagon formulation versus insulin-only closed loop system compared to a predictive low glucose suspend system: an open label, outpatient, single center, crossover, randomized control trial

50. Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial

Catalog

Books, media, physical & digital resources